SES - Delayed Quote SGD

Livingstone Health Holdings Limited (PRH.SI)

0.0160 0.0000 (0.00%)
At close: April 18 at 5:06 PM GMT+8
Loading Chart for PRH.SI
DELL
  • Previous Close 0.0160
  • Open 0.0160
  • Bid 0.0160 x --
  • Ask 0.0160 x --
  • Day's Range 0.0160 - 0.0160
  • 52 Week Range 0.0160 - 0.0700
  • Volume 152,900
  • Avg. Volume 25,229
  • Market Cap (intraday) 7.871M
  • Beta (5Y Monthly) -0.11
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date May 30, 2024 - Jun 3, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date Aug 19, 2022
  • 1y Target Est --

Livingstone Health Holdings Limited, an investment holding company, provides medical treatment and consultancy services in Singapore. It offers various medical services in the fields of anesthesiology and pain management, endocrinology, gastroenterology, orthopedic surgery, podiatry, physiotherapy, and aesthetics and wellness through primary care clinics, private medical specialists, and allied health care professionals. The company also provides other paramedical products and services, such as project consultancy services. It operates with a network of medical doctors and healthcare professionals. The company was founded in 2015 and is headquartered in Singapore. Livingstone Health Holdings Limited is a subsidiary of Livingstone Health Consolidated Pte. Ltd.

www.livingstonehealth.com.sg

99

Full Time Employees

March 31

Fiscal Year Ends

Related News

Performance Overview: PRH.SI

Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

PRH.SI
46.67%
STI Index
1.97%

1-Year Return

PRH.SI
77.14%
STI Index
4.02%

3-Year Return

PRH.SI
92.11%
STI Index
0.79%

5-Year Return

PRH.SI
96.77%
STI Index
5.11%

Compare To: PRH.SI

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PRH.SI

Valuation Measures

As of 4/19/2024
  • Market Cap

    7.87M

  • Enterprise Value

    12.03M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.23

  • Price/Book (mrq)

    1.50

  • Enterprise Value/Revenue

    0.40

  • Enterprise Value/EBITDA

    4.23

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -0.34%

  • Return on Assets (ttm)

    1.50%

  • Return on Equity (ttm)

    3.68%

  • Revenue (ttm)

    29.88M

  • Net Income Avi to Common (ttm)

    -102.31k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.22M

  • Total Debt/Equity (mrq)

    102.86%

  • Levered Free Cash Flow (ttm)

    3.23M

People Also Watch